Risks of Proteinuria and Hypertension With Bevacizumab, an Antibody Against Vascular Endothelial Growth Factor: Systematic Review and Meta-Analysis

2007623 citationsReview

Authors

Good health and well-being

Published in: American Journal of Kidney Diseases

Volume 49, Issue 2, pp. 186-193

Field-Weighted Citation Impact: 22.36